U.S. vaccine panel reverses hepatitis B guidance
Go Deeper.
Create an account or log in to save stories.
Like this?
Thanks for liking this story! We have added it to a list of your favorite stories.
A federal vaccine advisory committee recently voted to end the decades-old recommendation that all U.S. newborns get a hepatitis B vaccine dose at birth.
The Advisory Committee on Immunization Practices voted that only infants born to mothers who test positive for hepatitis B — or whose infection status is unknown — are recommended to get that first dose immediately.
The vote could result in new guidelines from the Centers for Disease Control and Prevention and is a dramatic shift from the CDC’s current policy, which was adopted in 1991 and is credited with reducing childhood hepatitis B infections by more than 95 percent.
MPR News guest host Chris Farrell talks with a pediatrician and an infectious disease researcher about what the new recommendation means for families, hospitals and communities in Minnesota that are disproportionately affected by the liver infection.
Turn Up Your Support
MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all.
Guests:
Dr. Leslie King-Schultz is a pediatrician at Hennepin Healthcare where she co-chairs their vaccine committee.
Angela Ulrich is a researcher and infectious disease epidemiologist with the Center for Infectious Disease Research and Policy at the University of Minnesota. She was one of the lead authors on the Vaccine Integrity Project’s recent report about the safety and effectiveness of the hepatitis B vaccination at birth.
Correction (Dec. 9, 2025): A previous version of this story misidentified the committee Dr. King-Schultz serves on.
Subscribe to the MPR News with Angela Davis podcast on: Apple Podcasts, Spotify or RSS.
Use the audio player above to listen to the full conversation.
